PEG-IFN-α-2a therapy in patients with myelofibrosis

被引:47
|
作者
Ianotto, Jean-Christophe [1 ]
Kiladjian, Jean-Jacques [2 ]
Demory, Jean-Louis [3 ]
Roy, Lydia [4 ]
Boyer, Francoise [5 ]
Rey, Jerome [6 ]
Dupriez, Brigitte [7 ]
Berthou, Christian [1 ]
Abgrall, Jean-Francois [8 ]
机构
[1] Hop Morvan, CHU, Inst Canc Hematol, Serv Hematol Clin, Brest, France
[2] AP HP, Serv Hematol Clin, Bobigny, France
[3] Hop St Vincent, Dept Hematol, Lille, France
[4] CHU La Miletrie, Dept Oncohematol & Therapie Cellulaire, Poitiers, France
[5] CHU Angers, Serv Malad Sang, Angers, France
[6] Inst J Paoli I Calmettes, Dept Oncohematol, F-13009 Marseille, France
[7] CH, Serv Hematol Clin, Lens, France
[8] CHU Brest, Hop Cavale Blanche, Hematol Lab, F-29285 Brest, France
关键词
myelofibrosis; treatment; pegylated-interferon; response criteria; European Myelofibrosis Network; MYELOID METAPLASIA; POLYCYTHEMIA-VERA; INTERFERON; CRITERIA;
D O I
10.1111/j.1365-2141.2009.07745.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:223 / 225
页数:3
相关论文
共 50 条
  • [31] European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response
    Dimitroulopoulos, Dimitrios
    Elefsiniotis, Ioannis
    Pavlidis, Christos
    Xinopoulos, Dimitrios
    Tsamakidis, Klisthenis
    Patsavela, Stamatina
    Kypreos, Dimitrios
    Ferderigou, Ageliki
    Korkolis, Dimitrios
    Koutsounas, Sotirios
    Saroglou, Georgios
    Paraskevas, Emmanouil
    HEPATITIS MONTHLY, 2010, 10 (03) : 193 - 198
  • [32] Virological Responses in Chronic Hepatitis C Patients Undergoing Prolonged Therapy with Low-Dose Peg-IFNα-2a
    Zhou, Jun-Ying
    Jiang, Zhi-An
    Zhou, Dong-Fang
    Xing, Wen-Li
    Wang, Wei
    Wang, Ya-Dong
    HEPATO-GASTROENTEROLOGY, 2013, 60 (122) : 301 - 304
  • [33] Improved Efficacy by Individualized Combination Therapy with Peg IFN-α 2a and ADV in HBeAg Positive Chronic Hepatitis B Patients
    Wang, Ya-Dong
    Zhao, Cai-Yan
    Wang, Wei
    Shen, Chuan
    Lu, Hong-Zhi
    Zhang, Li
    Yu, Wei-Yan
    Zhou, Jun-Ying
    Van, Wen-Zhao
    HEPATO-GASTROENTEROLOGY, 2012, 59 (115) : 680 - 686
  • [34] LETTER: Autoimmune Thrombocytopenia Induced by PEG-IFN-α2b Plus Ribavirin in Hepatitis C
    Abdurrahman Sagir
    Matthias Wettstein
    Tobias Heintges
    Dieter Häussinger
    Digestive Diseases and Sciences, 2002, 47 : 562 - 563
  • [35] Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients
    Lopez-Cortes, Luis F.
    Ruiz-Valderas, Rosa
    Jimenez-Jimenez, Luis
    Gonzalez-Escribano, Maria F.
    Torres-Cornejo, Almudena
    Mata, Rosario
    Rivero, Antonio
    Pineda, Juan A.
    Marquez-Solero, Manuel
    Viciana, Pompeyo
    PLOS ONE, 2012, 7 (01):
  • [36] PHARMACOKINETICS OF PEG-INTERFERON LAMBDA (PEG-IFN-λ) IN A DOSE-RANGING PHASE 1B STUDY IN HEPATITIS C PATIENTS
    Byrnes-Blake, K. A.
    Freeman, J. A.
    Dodds, M. G.
    Rapalus, L.
    Pederson, S.
    Hunder, N.
    Miller, D. M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S117 - S117
  • [37] Early results of peg-IFN α-2a treatment in chronic hemodialysis patients with chronic c hepatitis
    Strain, M. H.
    Patrascu, M.
    Strain, R. D.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S146 - S147
  • [38] Response to: Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN- based therapy in patients with CHB'
    Wu, Di
    Huang, Da
    Yan, Weiming
    Ning, Qin
    JOURNAL OF HEPATOLOGY, 2023, 79 (05) : E204 - E206
  • [39] Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a
    White, Joleen T.
    Crossman, Mary
    Richter, Kelly
    Berman, Melissa
    Goyal, Jaya
    Subramanyam, Meena
    BIOANALYSIS, 2015, 7 (21) : 2801 - 2811
  • [40] Global transcriptional effects of PEG-IFN-α and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C
    Balan, Vijayan
    Aravind, L.
    Grill, Diane E.
    Therneau, Terry M.
    Sulkowski, Mark S.
    Nelson, David R.
    Praestgaard, Jens
    Rosati, Marianne
    Birse, Charles E.
    Moore, Paul A.
    Subramanian, G. Mani
    HEPATOLOGY RESEARCH, 2006, 36 (04) : 277 - 287